non-animal-derived liquid toxin formulation
Scope
Date
~
-
Bio & Pharma
Daewoong’s Nabota expands into Germany, Austria
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday it had launched its botulinum toxin product Nabota in Germany and Austria through i...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Dubai delegation conducts due diligence on Medytox's plant in Korea
South Korea's biopharmaceutical firm Medytox Inc. said on Monday that a high-level delegation led by Dubai Science Park (DSP) under Dubai's state-ow...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Jetema applies to test its botulinum toxin in US from July
South Korea's bio-esthetic pharmaceutical company Jetema Co. will hold clinical trials in the US to advance to the American market, the world's bigg...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle
Following its lawsuit against Daewoong Pharmaceutical, South Korea's Medytox Inc. is waging an all-out legal war against domestic counterpart Hugel ...
Feb 24, 2023 (Gmt+09:00)
-
Energy
Samyang to develop biomaterials for battery heat management
South Korea’s Samyang Corp. signed a partnership agreement with local tech venture Nano Tim on Feb. 20 to jointly develop thermal interface ma...
Feb 22, 2023 (Gmt+09:00)
-
Economy
Korean jobs up by 22-month low of 411,000 in Jan, with signs of cooling
South Korea added the smallest number of payrolls in nearly two years in January, with mainly part-time jobs taken by people in their 60s and older,...
Feb 15, 2023 (Gmt+09:00)
-
Cloud computing
Hancom goes global with SDK, SaaS products
South Korea’s homegrown office suite developer Hancom Inc. will seek to boost its brand awareness in the global B2B software market with softw...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Korean stock market
Korea Exchange seeks to extend derivatives trading hours
South Korea’s bourse operator is seeking to extend derivatives trading hours by opening the market 15 minutes earlier at 8:45 am and allow for...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
CMG Pharma acquires animal nutrition company ING Medix
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, said on Monday that it is moving into the pet nutrition supplement market by acquirin...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to build plant for finished toxin products in Dubai
South Korea's biopharmaceutical company Medytox Inc. will build a plant for finished products containing botulinum toxin in the United Arab Emirates...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Capital raising
Lotte E&C, Meritz Securities conclude $1.2 billion investment deal
Lotte Engineering & Construction (E&C) has secured financing of 1.5 trillion won ($1.2 billion).The company on Monday announced its conclusi...
Jan 10, 2023 (Gmt+09:00)
-
Corporate restructuring
Korea’s Daol to sell another unit to secure liquidity
South Korea’s Daol Financial Group agreed to sell another unit as part of its efforts to raise money in preparations for a possible liquidity ...
Jan 06, 2023 (Gmt+09:00)
-
Metaverse
Caliverse, KT Alpha join hands to add K-pop to metaverse
Caliverse, a subsidiary of Lotte Data Communication, said on Thursday that it has signed an agreement to expand the range of immersive metaverse con...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Banking & Finance
Shinhan Bank to completely scrap mobile, online balance transfer fees
Beginning on New Year's day, Shinhan Bank started waiving all balance transfer fees to other bank accounts and automated transfer fees for its mobil...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Alteogen signs $145 million tech export deal with Swiss company
South Korea's bio company Alteogen Inc. on Friday said it signed its fourth technology export contract since its 2018 development of the human recom...
Dec 30, 2022 (Gmt+09:00)
-
Asset management
US non-agency mortgage-backed securities to shine in 2023: TCW
Amid the tightening of the Federal Reserve, among the most impacted asset classes were agency mortgage-backed securities (MBS), issued by US governm...
Dec 22, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korea's CMG Pharmaceutical opens animal medicine unit
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, on Monday announced the launch of an animal medicine unit and entry into the market f...
Dec 20, 2022 (Gmt+09:00)
-
Energy
SGC Energy signs 10-year contract to supply liquid CO2
South Korea’s SGC Energy Co. recently signed a contract to supply liquid carbon dioxide to a domestic company for 10 years starting January 20...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Helixmith acquires US patent on new freeze-dried formulation
South Korea's biotech company Helixmith Co. said Wednesday it has developed and patented a new freeze-dried formulation for Engensis (VM202), a non-...
Dec 15, 2022 (Gmt+09:00)
-
Hydrogen economy
S.Korea leads liquid hydrogen fuel tank technology standards
South Korea's draft proposal on aviation liquid hydrogen fuel tanks was adopted as an international standard at the International Organization for S...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
MDimune signs research agreement with Australian National University
MDimune, a South Korean biotech company, said on Wednesday that it had signed an agreement with the Clear Vision Research (CVR) Lab, a research grou...
Dec 07, 2022 (Gmt+09:00)
-
Venture capital
Daol Financial Group to let go of VC affiliate, hit by liquidity crunch
The Daol Financial Group is widely expected to let go of its venture capital arm in the midst of a worsening liquidity crunch. The VC firm Daol...
Dec 06, 2022 (Gmt+09:00)
-
Hydrogen economy
Lotte Chem, Air Liquide Korea launch JV for hydrogen business
South Korea’s chemical firm Lotte Chemical Corp. and Air Liquide Korea, the Korean unit of the French company Air Liquide SA, announced on Tue...
Dec 06, 2022 (Gmt+09:00)
-
Leadership & Management
Lotte to replace construction unit CEO due to liquidity crisis
Lotte Group will replace the head of its construction unit, hit by a liquidity crisis stemming from project financing, to ease investor concerns ove...
Nov 22, 2022 (Gmt+09:00)